17:05 - 18:15
Viral subversion/evasion of host cell defenses
Main Auditorium
Oral presentations
17:05 - 17:30
Viral Subversion/Evasion-T05-IvT-01
Invited talk - 25 min
The generation of resistance by CRISPR-Cas adaptive immune systems
 
Peter Fineran, et al.
University of Otago, Dunedin, New Zealand
17:30 - 17:45
Viral Subversion/Evasion-T05-Oft-02
Offered talk - 15 min
Direct genomic acquisition of CRISPR spacers from RNA by a natural Reverse-Transcriptase-Cas1 fusion: Remembrance of RNA-things past
 
Sukrit Silas1, 2, Georg Mohr3, David Sidote3, Laura Markham3, Antonio Sanchez-Amat4, Devaki Bhaya5, Alan Lambowitz3, Andrew Fire1
1Department of Pathology, Stanford University, Stanford, United States, 2Department of Chemical and Systems Biology, Stanford University, Stanford, United States, 3Institute for Cellular and Molecular Biology, Department of Molecular Biosciences, University of Texas at Austin, Austin, United States, 4Department of Genetics and Microbiology, Universidad de Murcia, Murcia, United States, 5Department of Plant Biology, Carnegie Institution for Science, Stanford, United States
17:45 - 18:00
Viral Subversion/Evasion-T05-Oft-03
Offered talk - 15 min
The bacteriophage T4 MotB protein, a DNA binding protein, boosts the level of T4 late gene expression
 
Jennifer Patterson West1, L Aravind2, Deborah Hinton1
1Gene Expression and Regulation Section, Laboratory of Cell and Molecular Biology, NIDDK, National Institutes of Health, Bethesda, United States, 2Protein and Genome Evolution Research Group, NLM/NCBI, National Institutes of Health, Bethesda, United States
18:00 - 18:15
Viral Subversion/Evasion-T05-Oft-04
Offered talk - 15 min
CRISPR and anti-CRISPR interactions between archaea and their viruses
 
Fei He, Yuvaraj Bhoobalan, Xu Peng
Danish Archaea Center, Department of Biology, University of Copenhagen, Copenahgen, Denmark
18:15 - 18:30
Viral Subversion/Evasion-T05-Oft-05
Offered talk - 15 min
Viral escape mutants of enterobacterial phages susceptible to a bifunctional abortive infection system with Type III toxin-antitoxin functionality.
 
George Salmond1, Tim Blower1, 2, Peter Fineran1, 3, Chidi Akusobi1, Xinzhe Fang1, Ray Chai1, Bihe Chen1, Sam Kidman1, Nathalie Goeders1, Andy Day1
1Cambridge University, Cambridge, United Kingdom, 2University of Durham, Durham, United Kingdom, 3University of Otago, Dunedin, New Zealand